Telegram Group & Telegram Channel
国产首款斑秃新药获批!每天一粒,半年超六成患者重获浓密秀发

6月30日,恒瑞医药的JAK1抑制剂艾玛昔替尼获批新适应症,成为我国首个国产斑秃靶向药物,适用于成人重度斑秃患者。这是该药半年来获批的第4项适应症,此前已用于强直性脊柱炎、类风湿关节炎和特应性皮炎治疗。

临床试验显示,艾玛昔替尼疗效显著。在一项涉及330例重度斑秃患者的III期研究中,24周时8mg组40.6%的患者头皮脱发面积降至20%以下,52周时这一比例更是达到63.1%,远超安慰剂组的9%。安全性方面表现良好,未观察到新的安全性信号。

目前国内已有三款斑秃新药形成竞争格局,包括礼来的巴瑞替尼和辉瑞的利特昔替尼。相比进口药在美国的天价定价(巴瑞替尼年费用约48万人民币),国产药物在定价上更具优势,为广大脱发患者带来了新希望。

终于不用再为"地中海"发愁了,国产药给了秃头星人们重新做人的机会!


丁香园

📮分享投稿 ☘️频道 🍵茶馆
👍234😭4014👎12😇8🤣6😱4😁1🤝1



tg-me.com/TestFlightCN/34023
Create:
Last Update:

国产首款斑秃新药获批!每天一粒,半年超六成患者重获浓密秀发

6月30日,恒瑞医药的JAK1抑制剂艾玛昔替尼获批新适应症,成为我国首个国产斑秃靶向药物,适用于成人重度斑秃患者。这是该药半年来获批的第4项适应症,此前已用于强直性脊柱炎、类风湿关节炎和特应性皮炎治疗。

临床试验显示,艾玛昔替尼疗效显著。在一项涉及330例重度斑秃患者的III期研究中,24周时8mg组40.6%的患者头皮脱发面积降至20%以下,52周时这一比例更是达到63.1%,远超安慰剂组的9%。安全性方面表现良好,未观察到新的安全性信号。

目前国内已有三款斑秃新药形成竞争格局,包括礼来的巴瑞替尼和辉瑞的利特昔替尼。相比进口药在美国的天价定价(巴瑞替尼年费用约48万人民币),国产药物在定价上更具优势,为广大脱发患者带来了新希望。

终于不用再为"地中海"发愁了,国产药给了秃头星人们重新做人的机会!


丁香园

📮分享投稿 ☘️频道 🍵茶馆

BY 科技圈🎗在花频道📮


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/TestFlightCN/34023

View MORE
Open in Telegram


在花软件新闻投稿频道 Telegram | DID YOU KNOW?

Date: |

China’s stock markets are some of the largest in the world, with total market capitalization reaching RMB 79 trillion (US$12.2 trillion) in 2020. China’s stock markets are seen as a crucial tool for driving economic growth, in particular for financing the country’s rapidly growing high-tech sectors.Although traditionally closed off to overseas investors, China’s financial markets have gradually been loosening restrictions over the past couple of decades. At the same time, reforms have sought to make it easier for Chinese companies to list on onshore stock exchanges, and new programs have been launched in attempts to lure some of China’s most coveted overseas-listed companies back to the country.

The messaging service and social-media platform owes creditors roughly $700 million by the end of April, according to people briefed on the company’s plans and loan documents viewed by The Wall Street Journal. At the same time, Telegram Group Inc. must cover rising equipment and bandwidth expenses because of its rapid growth, despite going years without attempting to generate revenue.

在花软件新闻投稿频道 from us


Telegram 科技圈🎗在花频道📮
FROM USA